Tilray’s Aphria RX Receives Cannabis Trading License in Germany, Significantly Expanding Commercial Growth Opportunities NEUMÜNSTER, Germany, July 29, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), a global leader in medical cannabis research, cultivation, production, and...

Tilray Medical Granted Approval to Introduce Third Medical Cannabis Product in Portugal Tilray Medical receives second approval for new medical cannabis extract in Portugal: Tilray Oral Solution THC10:CBD10 or Tilray Solução Oral THC10:CBD10.

Tilray Receives First New Cannabis Cultivation License in Germany Under New Regulations New cannabis cultivation license allows Aphria RX to cultivate a range of higher quality medical cannabis produced in Germany.